299 related articles for article (PubMed ID: 29871889)
21. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
22. The Quaking RNA-binding proteins as regulators of cell differentiation.
Neumann DP; Goodall GJ; Gregory PA
Wiley Interdiscip Rev RNA; 2022 Nov; 13(6):e1724. PubMed ID: 35298877
[TBL] [Abstract][Full Text] [Related]
23. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
[TBL] [Abstract][Full Text] [Related]
24. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.
Chen SY; Teng SC; Cheng TH; Wu KJ
Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472
[TBL] [Abstract][Full Text] [Related]
25. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
[TBL] [Abstract][Full Text] [Related]
26. An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition.
Warzecha CC; Jiang P; Amirikian K; Dittmar KA; Lu H; Shen S; Guo W; Xing Y; Carstens RP
EMBO J; 2010 Oct; 29(19):3286-300. PubMed ID: 20711167
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
[TBL] [Abstract][Full Text] [Related]
28. QKI-5 regulates the alternative splicing of cytoskeletal gene ADD3 in lung cancer.
Wang JZ; Fu X; Fang Z; Liu H; Zong FY; Zhu H; Yu YF; Zhang XY; Wang SF; Huang Y; Hui J
J Mol Cell Biol; 2021 Aug; 13(5):347-360. PubMed ID: 33196842
[TBL] [Abstract][Full Text] [Related]
29. Resveratrol Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition by Increasing miR-200c Expression in HCT-116 Colorectal Cancer Cells.
Karimi Dermani F; Saidijam M; Amini R; Mahdavinezhad A; Heydari K; Najafi R
J Cell Biochem; 2017 Jun; 118(6):1547-1555. PubMed ID: 27918105
[TBL] [Abstract][Full Text] [Related]
30. Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma.
Li Q; Zhang C; Chen R; Xiong H; Qiu F; Liu S; Zhang M; Wang F; Wang Y; Zhou X; Xiao G; Wang X; Jiang Q
Cancer Lett; 2016 Dec; 383(1):28-40. PubMed ID: 27693631
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer.
Xu Q; Sun Q; Zhang J; Yu J; Chen W; Zhang Z
Carcinogenesis; 2013 Mar; 34(3):539-49. PubMed ID: 23188671
[TBL] [Abstract][Full Text] [Related]
32. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma.
Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N
Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572
[TBL] [Abstract][Full Text] [Related]
33. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
[TBL] [Abstract][Full Text] [Related]
34. The RNA-binding protein QKI controls alternative splicing in vascular cells, producing an effective model for therapy.
Caines R; Cochrane A; Kelaini S; Vila-Gonzalez M; Yang C; Eleftheriadou M; Moez A; Stitt AW; Zeng L; Grieve DJ; Margariti A
J Cell Sci; 2019 Aug; 132(16):. PubMed ID: 31331967
[TBL] [Abstract][Full Text] [Related]
35. p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer.
Shi L; Jackstadt R; Siemens H; Li H; Kirchner T; Hermeking H
Cancer Res; 2014 Jan; 74(2):532-42. PubMed ID: 24285725
[TBL] [Abstract][Full Text] [Related]
36. RAVER1 hinders lethal EMT and modulates miR/RISC activity by the control of alternative splicing.
Wedler A; Bley N; Glaß M; Müller S; Rausch A; Lederer M; Urbainski J; Schian L; Obika KB; Simon T; Peters LM; Misiak C; Fuchs T; Köhn M; Jacob R; Gutschner T; Ihling C; Sinz A; Hüttelmaier S
Nucleic Acids Res; 2024 Apr; 52(7):3971-3988. PubMed ID: 38300787
[TBL] [Abstract][Full Text] [Related]
37. Exo70 isoform switching upon epithelial-mesenchymal transition mediates cancer cell invasion.
Lu H; Liu J; Liu S; Zeng J; Ding D; Carstens RP; Cong Y; Xu X; Guo W
Dev Cell; 2013 Dec; 27(5):560-73. PubMed ID: 24331928
[TBL] [Abstract][Full Text] [Related]
38. Roles and Regulation of Epithelial Splicing Regulatory Proteins 1 and 2 in Epithelial-Mesenchymal Transition.
Göttgens EL; Span PN; Zegers MM
Int Rev Cell Mol Biol; 2016; 327():163-194. PubMed ID: 27692175
[TBL] [Abstract][Full Text] [Related]
39. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics.
Koutsaki M; Spandidos DA; Zaravinos A
Cancer Lett; 2014 Sep; 351(2):173-81. PubMed ID: 24952258
[TBL] [Abstract][Full Text] [Related]
40. Function of quaking in myelination: regulation of alternative splicing.
Wu JI; Reed RB; Grabowski PJ; Artzt K
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4233-8. PubMed ID: 11917126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
